Correspondence
2
3
4
Foster S, Vaughan R, Foster W, Califano J. Estimate of the commercial value of underage drinking and adult abusive and dependent drinking to the alcohol industry. Arch Pediatr Adolesc Med 2006; 160: 473–78.Stockwell T, Zhao J, Chikritzhs T, Green eld T. What did you drink yesterday? Public health relevance of a recent recall method used in the 2004 Australian National Drug Strategy Household Survey. Addiction 2008; 103: 919–28.
Casswell S, Thamarangsi T. Reducing the harm from alcohol: call to action. Lancet 2009; 373: 2247–57.
We have the tools and best practices to address them, but we need to ensure that they are applied and implemented.” Dental diseases are not a niche area of health. Only when oral health is incorporated within the chronic disease discourse will sustained progress be possible.
We declare that we have no con icts of interest.
*Habib Benzian, Martin Hobdell, Judith Mackay
habib.benzian@health-bureau.com
The Health Bureau Ltd, Haversham MK19 7DT, UK (HB); Department of Epidemiology and Public Health, University College London, London, UK (MH); and World Lung Foundation, New York, NY, USA (JM)
Putting teeth into chronic diseases
Robert Geneau and colleagues1 high-light that public-health priorities and
political priorities are not necessarily 1 Geneau R, Stuckler D, Stachenko S, et al.
Raising the priority of preventing chronic
aligned. We could not agree more diseases: a political process. Lancet 2010;
376: 1689–98.with their conclusion that the “neglect
2 The Lancet. Oral health: prevention is key.
of chronic diseases is a political, not a Lancet 2009; 373: 1.technical, failure since cost-e ective 3 World Health Organization. Oral health: action
plan for promotion and integrated disease interventions are available”.
prevention. World Health Assembly Resolution
However, the current discussions WHA60/R17 2007. doc.guandang.net
ebwha/pdf_ les/WHA60/A60_16-en.pdf risk falling into the same trap by
(accessed Jan 24, 2011).
neglecting the most prevalent chronic
4 Beaglehole R, Benzian H, Crail J, Mackay J.
disease worldwide—dental decay. The oral health atlas: mapping a neglected
global health issue. Geneva & Brighton: FDI The global e ect of oral diseases
World Dental Education Ltd & Myriad Editions,
on health and health systems (oral 2009.
diseases rank fourth in terms of 5 Petersen PE, Bourgeois D, Ogawa H,
Estupinan-Day S, Ndiaye C. The global burden health-system costs) is largely ignored
of oral diseases and risks to oral health.
or underestimated.2,3Bull World Health Organ 2005; 83:

661–69.The global epidemic of dental decay a ects more than 90% of the world’s
population: between 40% and 90% Anticoagulation: of 12-year-olds have dental decay and I declare that I have no con icts of interest.improve care quality or its consequences, such as pain, chronic
Joyce H S Youinfection, absenteeism, low quality of use new alternatives?joyceyou@cuhk.edu.hk
life, and e ects on growth, develop-ment, and educational performance. Lars Wallentin and colleagues (Sept 18, School of Pharmacy, Faculty of Medicine, Chinese
University of Hong Kong, Shatin, NT, Hong Kong,
In low-resource countries almost all p 975)1 reanalysed results of the RE-LY SAR Chinadecay remains untreated.4,5trial to assess the interaction between 1 Wallentin L, Yusuf S, Ezekowitz MD, et al.
E cacy and safety of dabigatran compared Stakeholders in global oral health quality of anticoagulation care in each
with warfarin at di erent levels of
have not succeeded in framing the study centre (measured as the centre’s international normalised ratio control for problem in a way that resonates with mean time in therapeutic range stroke prevention in atrial brillation: an
analysis of the RE-LY trial. Lancet. 2010; ments broader public-health agendas. We [cTTR]) and clinical improve
376: 975–83.
are concerned that oral health, once seen with dabigatran compared with 2 Chan FWH, Wong RSM, Lau WH, et al.
Management of Chinese patients on warfarin brillation. All cardio-again, will be neglected in favour of warfarin in atrial
therapy in two models of anticoagulation
other disease entities simply because vascular events and total mortality service—a prospective randomized trial. they have more visible advocacy rates were reduced with dabigatran at Br J Clin Pharmacol 2006; 62: 601–09.
3 Ho LY, Siu CW, Yue WS, et al. Safety and low cTTR sites.campaigns.
e cacy of oral anticoagulation therapy in
Despite the clear evidence for war farin In January, 2007, the WHO Director-Chinese patients with concomitant atrial
brillation and hypertension. J Hum Hypertens General said that “oral diseases are a in the prevention of ischaemic stroke
2010; published online July 1. DOI:10.1038/
brillation, neglected area of international health. for patients with atrial jhh.2010.57.
464
doc.guandang.net Vol 377 February 5, 2011
warfarin underuse is common owing
to the complexity of anticoagulation care. In Hong Kong, the best anticoagulation care was achieved in a pharmacist-managed anticoagulation service (mean TTR 64%), followed by a physician-managed anticoagulation service (59%), a cardiac outpatient service (50%), and routine medical care (42–45%).2–4 However, although it had the highest quality of anticoagulation care, this pharmacist-managed anti-coagulation service is the only one of its kind in Hong Kong. Most health-care systems in China do not have any anticoagulation services at all.
Genotype-guided dosing of war- farin was shown to be potentially cost-e ective in practice sites with low cTTR in a decision analysis,5 consistent with the conclusion of Wallentin and colleagues. Practice sites with low cTTRs should obviously consider new interventions, namely upgrading to an anticoagulation specialty service, and, in the near future, use of warfarin pharmacogenomics to guide dosing and use of new anticoagulants, since these sites are likely to bene t the most with the new inter ven tions. All these interventions have different costs and clinical and operational implications for clinicians and decision makers to consider.
Anticoagulation-- improv... 2页 1财富值 ... care 18页 2财富值 Alternatives 3页 免费 care ...You’ll also discover a variety of quality ...
半衰期短 CVVH without anticoagulation in high risk patients Tan HK. Intensive Care Med 2000,26:1652-1657 CVVH without anticoagulation in high risk patients...
Air quality in Britain. 2. Exercises. 1. ...11) I need to do something to improve my ...Lots of countries have no alternatives. They don...
Creative alternatives to traditional care can ... to improve workflow and to personalize care. ... deliver a quality, home-based healthcare solution...
t decide, you burden yourself with alternatives. ...Emotional energy has a kind of magical quality; ...B) The woman hopes to improve her English. C)...
for healthcare systems and quality of care ...simulation to analyze and improve health care ...alternatives at the planning stage, 2) the same...
via convergence-quality2.6 23.3 44 56.5 64...alternatives to expensive and complex in situ ...improve with advancing the collection of data from...
Use of Quality Control Circles - A Fad or Need_专业资料。维普资讯 http://www.cqvip.com ? 4? 4 CDMV16o1(06 ADo. N.20)1 Usfai nrlrls—Fd...
alternatives 比较经济学 comparative economics 比上不...Quality and Technical Supervision 过犹不及 going ... cut payroll to improve efficiency 剪彩 cut the ...
alternatives.41–43 Recently, a novel Mg melt ...difficult to control the quality of a cast strip...improve corrosion resistance.23,24,26 The more ...
热门文档